Does APIXABAN Cause Electrocardiogram st segment elevation? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Electrocardiogram st segment elevation have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
7
Reports of Electrocardiogram st segment elevation with APIXABAN
0.0%
of all APIXABAN reports
2
Deaths
4
Hospitalizations
How Dangerous Is Electrocardiogram st segment elevation From APIXABAN?
Of the 7 reports, 2 (28.6%) resulted in death, 4 (57.1%) required hospitalization.
Is Electrocardiogram st segment elevation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Electrocardiogram st segment elevation?
PROPOFOL (96)
FLUOROURACIL (91)
ASPIRIN (78)
OXALIPLATIN (73)
CAPECITABINE (71)
CLOZAPINE (69)
EPINEPHRINE (55)
QUETIAPINE (51)
CLOPIDOGREL BISULFATE (49)
ALBUTEROL (45)
Which APIXABAN Alternatives Have Lower Electrocardiogram st segment elevation Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ